Leptin and body fat in type 2 diabetes and monodrug therapy.

Leptin and body fat in type 2 diabetes and monodrug therapy.

Item
http://www.wikidata.org/entity/Q44392857
Metformin monotherapy for type 2 diabetes mellitusMetformin monotherapy for type 2 diabetes mellitusPlasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.Leptin levels in obese women with and without type 2 diabetes mellitus.Understanding insulin resistance. What are the clinical implications?Serum leptin level is reduced in non-obese subjects with type 2 diabetes.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus.Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients.
P2860

Leptin and body fat in type 2 diabetes and monodrug therapy.

Item
http://www.wikidata.org/entity/Q44392857
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Leptin and body fat in type 2 diabetes and monodrug therapy.
@en
Leptin and body fat in type 2 diabetes and monodrug therapy.
@nl
type
label
Leptin and body fat in type 2 diabetes and monodrug therapy.
@en
Leptin and body fat in type 2 diabetes and monodrug therapy.
@nl
prefLabel
Leptin and body fat in type 2 diabetes and monodrug therapy.
@en
Leptin and body fat in type 2 diabetes and monodrug therapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Leptin and body fat in type 2 diabetes and monodrug therapy.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921